Pearl Fisher

Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients

K C Cundy, Brent G. Petty, John F. Flaherty et al. · Antimicrobial Agents and Chemotherapy · 1995 · 204 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +12

(S)-1-[3-Hydroxy-2-(Phosphonylmethoxy)propyl]cytosine (Cidofovir): Results of a Phase I/II Study of a Novel Antiviral Nucleotide Analogue

Jacob Lalezari, William Drew, E. Glutzer et al. · The Journal of Infectious Diseases · 1995 · 196 citations

Medicine, Infectious Diseases, Pharmacology +17

Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria

Michael A. Polis, Katie Spooner, Barbara Baird et al. · Antimicrobial Agents and Chemotherapy · 1995 · 132 citations

Medicine, Pharmacokinetics, Pharmacology +17

Treatment With Intravenous (S)-1-[3-Hydroxy-2-(Phosphonylmethoxy)Propyl]-Cytosine Of Acyclovir-Resistant Mucocutaneous Infection With Herpes Simplexvirus In A Patient With Aids

Jacob Lalezari, William Drew, E. Glutzer et al. · The Journal of Infectious Diseases · 1994 · 96 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects

M. Wachsman, Brent G. Petty, K C Cundy et al. · Antiviral Research · 1996 · 95 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17